Burzynski Research Stock Performance
| BZYR Stock | USD 0.04 0.00 0.00% |
Burzynski Research holds a performance score of 4 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -3.06, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Burzynski Research are expected to decrease by larger amounts. On the other hand, during market turmoil, Burzynski Research is expected to outperform it. Use Burzynski Research information ratio, value at risk, as well as the relationship between the Value At Risk and kurtosis , to analyze future returns on Burzynski Research.
Risk-Adjusted Performance
4 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Burzynski Research are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Burzynski Research reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 62.00 |
Burzynski |
Burzynski Research Relative Risk vs. Return Landscape
If you would invest 4.10 in Burzynski Research on September 2, 2024 and sell it today you would lose (0.60) from holding Burzynski Research or give up 14.63% of portfolio value over 90 days. Burzynski Research is currently generating 1.002% in daily expected returns and assumes 16.7337% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Burzynski, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Burzynski Research Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Burzynski Research's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Burzynski Research, and traders can use it to determine the average amount a Burzynski Research's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0599
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BZYR | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 16.73 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.0 actual daily | 19 81% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Burzynski Research is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Burzynski Research by adding it to a well-diversified portfolio.
Burzynski Research Fundamentals Growth
Burzynski Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Burzynski Research, and Burzynski Research fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Burzynski Pink Sheet performance.
| Return On Asset | -127.66 | |||
| Current Valuation | 2.65 M | |||
| Shares Outstanding | 131.45 M | |||
| Price To Earning | (5.25) X | |||
| Price To Book | 2,191 X | |||
| EBITDA | (976.66 K) | |||
| Cash And Equivalents | 1.27 K | |||
| Cash Flow From Operations | (325.1 K) | |||
| Earnings Per Share | (0.01) X | |||
| Total Asset | 4.66 K | |||
| Retained Earnings | (118.04 M) | |||
| Current Liabilities | 110 K | |||
About Burzynski Research Performance
Assessing Burzynski Research's fundamental ratios provides investors with valuable insights into Burzynski Research's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Burzynski Research is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs to treat cancer. Burzynski Research Institute, Inc. was founded in 1977 and is based in Houston, Texas. Burzynski Research is traded on OTC Exchange in the United States.Things to note about Burzynski Research performance evaluation
Checking the ongoing alerts about Burzynski Research for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Burzynski Research help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Burzynski Research is way too risky over 90 days horizon | |
| Burzynski Research has some characteristics of a very speculative penny stock | |
| Burzynski Research appears to be risky and price may revert if volatility continues | |
| The company has a current ratio of 0.11, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Burzynski Research until it has trouble settling it off, either with new capital or with free cash flow. So, Burzynski Research's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Burzynski Research sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Burzynski to invest in growth at high rates of return. When we think about Burzynski Research's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (976.66 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Burzynski Research currently holds about 1.27 K in cash with (325.1 K) of positive cash flow from operations. | |
| Roughly 81.0% of the company shares are held by company insiders |
- Analyzing Burzynski Research's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Burzynski Research's stock is overvalued or undervalued compared to its peers.
- Examining Burzynski Research's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Burzynski Research's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Burzynski Research's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Burzynski Research's pink sheet. These opinions can provide insight into Burzynski Research's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Burzynski Pink Sheet Analysis
When running Burzynski Research's price analysis, check to measure Burzynski Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Burzynski Research is operating at the current time. Most of Burzynski Research's value examination focuses on studying past and present price action to predict the probability of Burzynski Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Burzynski Research's price. Additionally, you may evaluate how the addition of Burzynski Research to your portfolios can decrease your overall portfolio volatility.